Health Canada drug identification number

DIN 02393352 — RIASTAP 1000 MG

RIASTAP is a powder for solution of Fibrinogen marketed by CSL BEHRING CANADA INC. The full Fibrinogen monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02393352
Brand name
RIASTAP
Active ingredient
Fibrinogen
Strength
1000 MG
Dosage form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
CSL BEHRING CANADA INC
Health Canada status
MARKETED
Drug class
Plasma-derived coagulation factor (fibrinogen replacement, blood product)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Fibrinogen products

DINBrandStrengthFormManufacturerStatus
02464616 FIBRYGA 1 G POWDER FOR SOLUTION OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.